SCD and neoplasm: These results, in conjunction with those of our clinical trial, suggest that downregulation of SCD-1 by n-3FA and DHA in particular may not be tumor protective in non-obese women (at least as determined by a reduction in breast density) but may be selectively protective in obese subjects where decreasing levels of SCD-1 were associated with a progressive decrease in absolute breast density.